Literature DB >> 18648397

Detailed phenotype-genotype study in five patients with chromosome 6q16 deletion: narrowing the critical region for Prader-Willi-like phenotype.

Maria Clara Bonaglia1, Roberto Ciccone, Giorgio Gimelli, Stefania Gimelli, Susan Marelli, Joke Verheij, Roberto Giorda, Rita Grasso, Renato Borgatti, Filomena Pagone, Laura Rodrìguez, Maria-Luisa Martinez-Frias, Conny van Ravenswaaij, Orsetta Zuffardi.   

Abstract

Most patients with an interstitial deletion of 6q16 have Prader-Willi-like phenotype, featuring obesity, hypotonia, short hands and feet, and developmental delay. In all reported studies, the chromosome rearrangement was detected by karyotype analysis, which provides an overview of the entire genome but has limited resolution. Here we describe a detailed clinical presentation of five patients, two of whom were previously reported, with overlapping interstitial 6q16 deletions and Prader-Willi-like phenotype. Our patients share the following main features with previously reported cases: global developmental delay, hypotonia, obesity, hyperphagia, and eye/vision anomalies. All rearrangement breakpoints have been accurately defined through array-CGH at about 100 Kb resolution. We were able to narrow the shortest region of deletion overlap for the presumed gene(s) involved in the Prader-Willi-like syndrome to 4.1 Mb located at 6q16.1q16.2. Our results support the evidence that haploinsufficiency of the SIM1 gene is responsible for obesity in these patients. A possible involvement of the GRIK2 gene in autistic-like behaviour, of POPDC3 in heart development, and of MCHR2 in the control of feeding behaviour and energy metabolism is also hypothesized.

Entities:  

Mesh:

Year:  2008        PMID: 18648397     DOI: 10.1038/ejhg.2008.119

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  32 in total

1.  Replication and extension of association between common genetic variants in SIM1 and human adiposity.

Authors:  Michael M Swarbrick; Daniel S Evans; Maria I Valle; Hélène Favre; Shi-Hsuan Wu; Omer T Njajou; Rongling Li; Joseph M Zmuda; Iva Miljkovic; Tamara B Harris; Pui-Yan Kwok; Christian Vaisse; Wen-Chi Hsueh
Journal:  Obesity (Silver Spring)       Date:  2011-04-21       Impact factor: 5.002

2.  Interstitial Deletions at 6q14.1-q15 Associated with Obesity, Developmental Delay and a Distinct Clinical Phenotype.

Authors:  C Wentzel; S A Lynch; E-L Stattin; F H Sharkey; G Annerén; A-C Thuresson
Journal:  Mol Syndromol       Date:  2010-06-09

3.  Functional characterization of SIM1-associated enhancers.

Authors:  Mee J Kim; Nir Oksenberg; Thomas J Hoffmann; Christian Vaisse; Nadav Ahituv
Journal:  Hum Mol Genet       Date:  2013-11-07       Impact factor: 6.150

4.  Genotype-phenotype correlation in interstitial 6q deletions: a report of 12 new cases.

Authors:  Jill A Rosenfeld; Dina Amrom; Eva Andermann; Frederick Andermann; Martin Veilleux; Cynthia Curry; Jamie Fisher; Stephen Deputy; Arthur S Aylsworth; Cynthia M Powell; Kandamurugu Manickam; Bryce Heese; Melissa Maisenbacher; Cathy Stevens; Jay W Ellison; Sheila Upton; John Moeschler; Wilfredo Torres-Martinez; Abby Stevens; Robert Marion; Elaine Maria Pereira; Melanie Babcock; Bernice Morrow; Trilochan Sahoo; Allen N Lamb; Blake C Ballif; Alex R Paciorkowski; Lisa G Shaffer
Journal:  Neurogenetics       Date:  2012-01-05       Impact factor: 2.660

5.  Incomplete penetrance and phenotypic variability of 6q16 deletions including SIM1.

Authors:  Laïla El Khattabi; Fabien Guimiot; Eva Pipiras; Joris Andrieux; Clarisse Baumann; Sonia Bouquillon; Anne-Lise Delezoide; Bruno Delobel; Florence Demurger; Hélène Dessuant; Séverine Drunat; Christelle Dubourg; Céline Dupont; Laurence Faivre; Muriel Holder-Espinasse; Sylvie Jaillard; Hubert Journel; Stanislas Lyonnet; Valérie Malan; Alice Masurel; Nathalie Marle; Chantal Missirian; Alexandre Moerman; Anne Moncla; Sylvie Odent; Orazio Palumbo; Pietro Palumbo; Aimé Ravel; Serge Romana; Anne-Claude Tabet; Mylène Valduga; Marie Vermelle; Massimo Carella; Jean-Michel Dupont; Alain Verloes; Brigitte Benzacken; Andrée Delahaye
Journal:  Eur J Hum Genet       Date:  2014-11-05       Impact factor: 4.246

6.  Mutation screen of the SIM1 gene in pediatric patients with early-onset obesity.

Authors:  D Zegers; S Beckers; R Hendrickx; J K Van Camp; V de Craemer; A Verrijken; K Van Hoorenbeeck; S L Verhulst; R P Rooman; K N Desager; G Massa; L F Van Gaal; W Van Hul
Journal:  Int J Obes (Lond)       Date:  2013-10-07       Impact factor: 5.095

7.  Microdeletion of 6q16.1 encompassing EPHA7 in a child with mild neurological abnormalities and dysmorphic features: case report.

Authors:  Ryan N Traylor; Zheng Fan; Beth Hudson; Jill A Rosenfeld; Lisa G Shaffer; Beth S Torchia; Blake C Ballif
Journal:  Mol Cytogenet       Date:  2009-08-07       Impact factor: 2.009

8.  Evaluation of A2BP1 as an obesity gene.

Authors:  Lijun Ma; Robert L Hanson; Michael T Traurig; Yunhua L Muller; Bakhshish P Kaur; Jessica M Perez; David Meyre; Mao Fu; Antje Körner; Paul W Franks; Wieland Kiess; Sayuko Kobes; William C Knowler; Peter Kovacs; Philippe Froguel; Alan R Shuldiner; Clifton Bogardus; Leslie J Baier
Journal:  Diabetes       Date:  2010-08-19       Impact factor: 9.461

9.  Interstitial deletions at 6q14.1q15 associated with developmental delay and a marfanoid phenotype.

Authors:  R B Lowry; J E Chernos; M S Connelly; J P H Wyse
Journal:  Mol Syndromol       Date:  2013-08-01

10.  Loss-of-function mutations in SIM1 contribute to obesity and Prader-Willi-like features.

Authors:  Amélie Bonnefond; Anne Raimondo; Fanny Stutzmann; Maya Ghoussaini; Shwetha Ramachandrappa; David C Bersten; Emmanuelle Durand; Vincent Vatin; Beverley Balkau; Olivier Lantieri; Violeta Raverdy; François Pattou; Wim Van Hul; Luc Van Gaal; Daniel J Peet; Jacques Weill; Jennifer L Miller; Fritz Horber; Anthony P Goldstone; Daniel J Driscoll; John B Bruning; David Meyre; Murray L Whitelaw; Philippe Froguel
Journal:  J Clin Invest       Date:  2013-06-17       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.